Furthermore, the use of a liver conditional Sirt2 knockout mouse would provide better insights into the observed whole-body phenotype; specifically, the observation of fewer TAMs in Sirt2−/− HCC. This evidence concerns the gene SIRT2 and hepatocellular carcinoma.